Shorter duration of protection and lower geometric mean titers against A/H3N2 antigen of the quadrivalent influenza vaccine in children post-allogeneic hematopoietic stem cell transplantation.

Bone Marrow Transplant · 2022 · PMC9342841 · PMID 35915154

Europe PMC DOI

hedged sentence

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

showed a trendP = 0.067so close (0.05 < p ≤ 0.1)

The chemotherapy group showed a trend towards a lower GMT (84.1; 95% CI, 40.0–216.0) compared to the control group (195.0; 95% CI, 40.0–539.9) ( P = 0.067) at 3–6 months post-vaccination.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.